NCT03292822View on ClinicalTrials.gov

Effects of (Licochalcone A) and Paclitaxel on Human Oral Squamous Cell Carcinoma Cell Line

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 15, 2021

Primary Completion Date

January 1, 2023

Study Completion Date

December 1, 2023

Conditions

Squamous Cell Carcinoma

Interventions

DIETARY_SUPPLEMENT

Licochalcone A

Licochalcone A is a chalconoid, a type of natural phenols. It can be isolated from root of Glycyrrhiza glabra (liquorice) or Glycyrrhiza inflata. It shows antimalarial, anticancer, antibacterial and antiviral (specifically against influenza neuraminidase) properties in vitro.

DRUG

Paclitaxel

chemotherapeutic drug

Trial Locations (1)

Unknown

Cairo University, Cairo

All Listed Sponsors

lead

Cairo University

OTHER

NCT03292822 - Effects of (Licochalcone A) and Paclitaxel on Human Oral Squamous Cell Carcinoma Cell Line | Biotech Hunter | Biotech Hunter